General MedicationsVIALStandard
AVONEX
INTERFERON BETA-1A
Standard Dose
30UG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview AVONEX is listed in Drugs@FDA under application 103628 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient INTERFERON BETA-1A Form and strength VIAL - 30UG/ML Sponsor BIOGEN Submission history Latest submission status date: 2023-07-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview AVONEX is listed in Drugs@FDA under application 103628 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient INTERFERON BETA-1A Form and strength VIAL - 30UG/ML Sponsor BIOGEN Submission history Latest submission status date: 2023-07-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.